Ultrasound in Assessing Antiangiogenic Treatment in Patients With Advanced Kidney Cancer

NCT01105364 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

50

Enrollment

OTHER_GOV

Sponsor class

Conditions

Kidney Cancer
Metastatic Cancer

Interventions

DRUG: antiangiogenesis therapy
DRUG: stabilized sulphur hexafluoride microbubble-based contrast agent
OTHER: imaging biomarker analysis
OTHER: pharmacological study
PROCEDURE: computed tomography
PROCEDURE: magnetic resonance imaging

Sponsor

National Cancer Institute, France